NASDAQ:GRAL Grail (GRAL) Stock Price, News & Analysis $26.93 -1.65 (-5.77%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$27.50 +0.57 (+2.12%) As of 03/28/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Grail Stock (NASDAQ:GRAL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Grail alerts:Sign Up Key Stats Today's Range$26.16▼$28.9950-Day Range$17.42▼$55.0252-Week Range$12.33▼$63.99Volume949,031 shsAverage Volume1.22 million shsMarket Capitalization$912.79 millionP/E RatioN/ADividend YieldN/APrice Target$20.00Consensus RatingHold Company OverviewGRAIL, Inc. is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.Read More… Remove Ads Grail Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks15th Percentile Overall ScoreGRAL MarketRank™: Grail scored higher than 15% of companies evaluated by MarketBeat, and ranked 894th out of 935 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingHold Consensus RatingGrail has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageGrail has only been the subject of 1 research reports in the past 90 days.Read more about Grail's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Grail are expected to grow in the coming year, from ($15.15) to ($12.95) per share.Read more about Grail's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted12.61% of the float of Grail has been sold short.Short Interest Ratio / Days to CoverGrail has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Grail has recently decreased by 4.67%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldGrail does not currently pay a dividend.Dividend GrowthGrail does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted12.61% of the float of Grail has been sold short.Short Interest Ratio / Days to CoverGrail has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Grail has recently decreased by 4.67%, indicating that investor sentiment is improving. News and Social Media3.0 / 5News Sentiment1.37 News SentimentGrail has a news sentiment score of 1.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.81 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Grail this week, compared to 6 articles on an average week.Search Interest17 people have searched for GRAL on MarketBeat in the last 30 days. This is an increase of 70% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Grail to their MarketBeat watchlist in the last 30 days. This is a decrease of -91% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Grail insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $360,436.00 in company stock.Read more about Grail's insider trading history. Receive GRAL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Grail and its competitors with MarketBeat's FREE daily newsletter. Email Address GRAL Stock News HeadlinesAaron Freidin Sells 1,816 Shares of Grail, Inc. (NASDAQ:GRAL) StockMarch 13, 2025 | insidertrades.comGrail (NASDAQ:GRAL) Stock Price Expected to Rise, Morgan Stanley Analyst SaysMarch 20, 2025 | americanbankingnews.comNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America. March 30, 2025 | Paradigm Press (Ad)Grail price target raised to $20 from $16 at Morgan StanleyMarch 19, 2025 | markets.businessinsider.comGRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)February 26, 2025 | prnewswire.comGRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection TestingFebruary 25, 2025 | prnewswire.comWhy Grail (GRAL) Is Falling TodayFebruary 21, 2025 | msn.comGRAIL to Present at TD Cowen 45th Annual Health Care ConferenceFebruary 21, 2025 | prnewswire.comSee More Headlines GRAL Stock Analysis - Frequently Asked Questions How have GRAL shares performed this year? Grail's stock was trading at $17.85 at the start of the year. Since then, GRAL stock has increased by 50.9% and is now trading at $26.93. View the best growth stocks for 2025 here. How were Grail's earnings last quarter? Grail, Inc. (NASDAQ:GRAL) issued its quarterly earnings results on Thursday, February, 20th. The company reported ($1.86) earnings per share for the quarter, topping the consensus estimate of ($4.41) by $2.55. The company had revenue of $38.25 million for the quarter, compared to analyst estimates of $35.33 million. Who are Grail's major shareholders? Grail's top institutional shareholders include Crcm LP (10.85%), Sessa Capital IM L.P. (8.93%), Primecap Management Co. CA (6.19%) and Baker BROS. Advisors LP (4.85%). Insiders that own company stock include Chun R Ding, Joshua J Ofman and Aaron Freidin. View institutional ownership trends. How do I buy shares of Grail? Shares of GRAL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Grail own? Based on aggregate information from My MarketBeat watchlists, some other companies that Grail investors own include NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Visa (V). Company Calendar Last Earnings2/20/2025Today3/30/2025Next Earnings (Estimated)5/15/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryHealthcare Current SymbolNASDAQ:GRAL Previous SymbolNASDAQ:GRAL CIK1699031 WebN/A Phone(650) 771-9796FaxN/AEmployees1,360Year FoundedN/APrice Target and Rating Average Stock Price Target$20.00 High Stock Price Target$20.00 Low Stock Price Target$20.00 Potential Upside/Downside-25.7%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio9.65 Quick Ratio9.65 Sales & Book Value Annual Sales$125.60 million Price / Sales7.27 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares33,895,000Free FloatN/AMarket Cap$912.79 million OptionableOptionable BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (NASDAQ:GRAL) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | SponsoredTrump… a socialist? Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Grail, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Grail With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.